CCOC(=O)c1cc(C2(OC)CCN(Cc3ccccc3)C2=O)c(-c2cc(C)no2)[nH]1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?